Suppr超能文献

环孢素诱导的红斑性肢痛症。

Cyclosporine-induced Erythromelalgia.

作者信息

Bibb Lorin A, Winter Randi P, Leicht Stuart S

机构信息

Dermatology, East Tennessee State University Quillen College of Medicine, Johnson City, USA.

出版信息

Cureus. 2018 Oct 27;10(10):e3506. doi: 10.7759/cureus.3506.

Abstract

Erythromelalgia is a neurovascular disorder which causes pain, swelling, erythema, and warmth of the distal extremities. Primary disease is due to a genetic mutation in the gene, but secondary erythromelalgia can be the consequence of a variety of underlying etiologies, including drug and toxin exposures. The disease is rare, occurring in only 1.3 out of every 100,000 in the United States, and symptoms can vary significantly in severity and presentation. Therefore, it can be difficult to recognize the disorder, identify the source, and promptly treat the condition. We report a reversible cause of erythromelalgia induced by the use of oral cyclosporine. This correlation is poorly documented in literature, with limited accounts identifying an association between erythromelalgia and cyclosporine. As drug-induced erythromelalgia represents a reversible cause of disease, physicians should obtain a detailed medication history during the diagnostic workup, specifically inquiring about the use of cyclosporine.

摘要

红斑性肢痛症是一种神经血管疾病,可导致远端肢体疼痛、肿胀、红斑和发热。原发性疾病是由该基因的基因突变引起的,但继发性红斑性肢痛症可能是多种潜在病因的结果,包括药物和毒素暴露。这种疾病很罕见,在美国每10万人中仅有1.3人发病,症状的严重程度和表现差异很大。因此,识别这种疾病、确定病因并及时治疗可能很困难。我们报告了一例因使用口服环孢素引起的红斑性肢痛症的可逆病因。这种关联在文献中记载较少,仅有有限的报道指出红斑性肢痛症与环孢素之间存在关联。由于药物性红斑性肢痛症是一种可逆的病因,医生在诊断检查过程中应获取详细的用药史,特别要询问环孢素的使用情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef8b/6318136/24789bdac961/cureus-0010-00000003506-i01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验